{"disease":{"id":"malignant-skull-base-neoplasm","name":"malignant skull base neoplasm"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04265430","title":"Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":425,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT04296617","title":"Brain Imaging Changes Following Proton Therapy for Pediatric Primary Central Nervous System and Base of Skull Tumors","phase":"","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Mayo Clinic","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}